Dharmik Jadvani

Researcher

UAMS

Last publication 2025 Last refreshed 2026-05-16

unknown

1 h-index 6 pubs 9 cited

Research Areas

Links

ORCID

OverviewAI-generated summary

Dharmik Jadvani's research focuses on analyzing health outcomes and pharmacological effects, with a recent emphasis on cardiovascular health and chronic kidney disease. He has published work investigating the impact of P2Y12 receptor inhibitors on sepsis hospitalization in patients with chronic kidney disease and evaluating the cardiovascular outcomes associated with tetrahydrocannabinoids. Jadvani has also contributed to systematic reviews and meta-analyses concerning procedural modifications for permanent pacemaker implantation post-Transcatheter Aortic Valve Replacement. His publications include case reports and discussions on specific medical conditions such as Olmesartan-induced enteropathy and infective endocarditis. Jadvani's work often involves meta-analytical evaluations and systematic reviews, contributing to a growing body of literature on these specific medical topics. His scholarship metrics include an h-index of 1, with 6 total publications and 9 total citations.

Metrics

h-index: 1
Publications: 6
Citations: 9

Selected Publications

E-93 | Population-level Impact of Advancing Valvular Interventions on Mortality from Atrial Fibrillation and Flutter Among Adults with Nonrheumatic Valvular Heart Disease in the United States: A CDC-WONDER Analysis from 1999-2023 (2026)

DOI OpenAlex
Late Sinus of Valsalva Sequestration After Transcatheter Aortic Valve Implantation in Native Aortic Valve (2026)

DOI OpenAlex
26-A-18480-ACC INCIDENCE AND PREDICTORS OF HIGH-GRADE ATRIOVENTRICULAR BLOCK AFTER TRANSCATHETER TRICUSPID VALVE REPLACEMENT: A REAL-WORLD ANALYSIS (2026)

DOI OpenAlex
26-A-16106-ACC SODIUM-GLUCOSE COTRANSPORTER-2 INHIBITORS (SGLT2I) IN PULMONARY HYPERTENSION (PH): A SYSTEMATIC REVIEW (2026)

DOI OpenAlex
26-A-10911-ACC EFFECT OF GLUCAGON-LIKE RECEPTOR PEPTIDE-1 AGONISTS ON ATRIAL FIBRILLATION-RELATED EVENTS AND INCIDENCE IN CHRONIC KIDNEY DISEASE (2026)

DOI OpenAlex
Infective Endocarditis Involving the Chiari Network (2025)

DOI OpenAlex
Potent P2Y12 Receptor Inhibitors Reduce Risk for Hospitalization from Sepsis in Patients with CKD (2025)

DOI OpenAlex
E-34 | Procedural modification to risk stratify permanent pacemaker implantation post Transcatheter Aortic Valve Replacement: A Systematic Review and Meta-Analysis (2025)

DOI OpenAlex
E-115 | Tetra-Hydro-Cannabinoids and Cardiovascular Outcomes - A Meta-Analytical Evaluation of Arrhythmia and Mortality (2025)

DOI OpenAlex
Authors' Reply: Platelet Count, Platelet Volume and CKD (2024)

DOI OpenAlex